N23692
yw46b03.s1 Weizmann Olfactory Epithelium Homo sapiens cDNA clone IMAGE:255245 3' similar to contains Alu repetitive element;contains element TAR1 repetitive element, mRNA sequence.
407
mRNA
Homo sapiens
LV569514
JP 2017029159-A/23692: COMPOSITIONS AND METHODS FOR CREATING ALTERED AND IMPROVED CELLS AND ORGANISMS.
40
DNA
synthetic construct
DM798150
JP 2014068652-A/23692: NEISSERIAL ANTIGENIC PEPTIDES.
7
PRT
Neisseria
FU798173
JP 2009528046-A/23690: Method for identifying useful proteins of brewery yeast.
25
DNA
Saccharomyces pastorianus
MB812950
JP 2019502674-A/23692: COMPOUNDS FOR INDUCING TISSUE FORMATION AND USES THEREOF.
38
PRT
synthetic construct
DJ953057
JP 2010500568-A/39738: ORGAN-SPECIFIC PROTEINS AND METHODS OF THEIR USE.
259
PRT
Homo sapiens
HW858916
JP 2015051004-A/23644: Novel siRNA's and Use Thereof.
21
RNA
synthetic construct
PA339340
JP 2021522188-A/23692: Compositions and Methods for Multiplexed Tumor Vaccination with Endogenous Gene Activation.
20
DNA
synthetic construct
OG660078
JP 2021500321-A/23692: METHODS AND COMPOSITIONS FOR INHIBITING ADAM10 BIOLOGICAL ACTIVITIES.
189
PRT
synthetic construct
PA528176
JP 2022502046-A/10958: ADENO-ASSOCIATED VIRUS COMPOSITIONS FOR TARGETED GENE THERAPY.
21
DNA
synthetic construct
DD550295
JP 2004508801-A/23692: NEISSERIAL ANTIGENIC PEPTIDES.
7
PRT
Neisseria
DL905436
JP 2014205669-A/23692: Method of constructing and screening libraries of peptide structures.
15
PRT
synthetic construct
MC165536
JP 2019500349-A/23692: COMPOSITIONS AND METHODS FOR TREATMENT OF CENTRAL NERVOUS SYSTEM DISEASES.
18
RNA
synthetic construct
HZ528473
JP 2016501039-A/23692: COMPOSITIONS AND METHODS FOR CREATING ALTERED AND IMPROVED CELLS AND ORGANISMS.
40
DNA
synthetic construct
DJ153072
JP 2007228956-A/23690: Method for identification of useful proteins derived from brewery yeast.
25
DNA
Saccharomyces pastorianus
DM760386
JP 2014079248-A/23692: NEISSERIAL ANTIGENIC PEPTIDES.
7
PRT
Neisseria
DL032706
JP 2005512499-A/23692: Diagnosis of existing illnesses or that praedisposition for determined illnesses.
523
DNA
synthetic construct
MD755934
JP 2019507579-A/23692: MATERIALS AND METHODS FOR TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY.
20
DNA
synthetic construct
LX121308
JP 2017506877-A/23690: Analysis of Nucleic Acids Associated With Single Cells Using Nucleic Acid Barcodes.
16
DNA
synthetic construct
HV880233
JP 2010507387-A/23644: Novel siRNAs and Methods of Use Thereof.
21
RNA
synthetic construct
LF682913
JP 2016521556-A/23692: COMPOSITIONS AND METHODS FOR MODULATING FOXP3 EXPRESSION.
15
DNA
Homo sapiens
PA394415
JP 2021533803-A/23498: FASL IMMUNOMODULATORY GENE THERAPY COMPOSITIONS AND METHODS FOR USE.
26
DNA
Homo sapiens
DL614294
JP 2011092200-A/23692: NEISSERIAL ANTIGENIC PEPTIDES.
7
PRT
Neisseria
OG507878
JP 2018534252-A/23692: PHARMACEUTICAL ASSOCIATION FOR CONVERTING A NEOPLASTIC CELL INTO A NON-NEOPLASTIC CELL AND USES THEREOF.
38
PRT
synthetic construct
MC552192
JP 2019525738-A/23692: BISPECIFIC CHECKPOINT INHIBITOR ANTIBODIES.
108
PRT
synthetic construct
MD269825
JP 2020517247-A/23692: A Platform for T Lymphocyte Genome Engineering and In Vivo High-Throughput Screening Thereof.
20
DNA
synthetic construct
HW188720
JP 2013102767-A/23644: Novel siRNA's and Use Thereof.
21
RNA
synthetic construct
DJ527492
JP 2010517930-A/23692: Method of constructing and screening libraries of peptide structures.
15
PRT
synthetic construct
MB764062
JP 2018535655-A/27959: ASGR INHIBITORS.
9
PRT
synthetic construct
PD711606
JP 2021530475-A/23688: De novo Design of Protein Switches.
59
PRT
synthetic construct